LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Aandelen Lijst・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Gesloten

SectorGezondheidszorg

86.71 1.92

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Belangrijke statistieken
By Trading Economics
Inkomsten	99M 239M
Verkoop	-157M 2.1B
K/W Sectorgemiddelde	21.487 49.888
EPS	2.09
Dividendrendement	1.17
Winstmarge	11.43
Werknemers	17,000
EBITDA	84M 538M

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+14.05% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.17% 2.38%
Volgende Winsten	6 aug 2026
Volgende dividenddatum	31 jul 2026
Volgende Ex Dividend datum	25 jun 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-1.9B 16B
Vorige openingsprijs	84.79
Vorige sluitingsprijs	86.71

Nieuwssentiment

By Acuity

14%

86%

20 / 344 Rangschikking in Healthcare

Zimmer Biomet Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 nov 2025, 19:38 UTC

Winsten

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Winsten

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Peer Vergelijking

Prijswijziging

Zimmer Biomet Holdings Inc Prognose

Koersdoel

By TipRanks

14.05% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 96.92 USD 14.05%

Hoogste 109 USD

Laagste 83 USD

Gebaseerd op 16 Wall Street-analisten die 12-maands prijsdoelen bieden voor Zimmer Biomet Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

16 ratings

Buy

Hold

Sell

Gebaseerd op 16 analisten die aandelenratings hebben gegeven aan Zimmer Biomet Holdings Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

20 / 344 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.